Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453085 · ClinicalTrials.gov registry record · Phase 1
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)
A Phase 1 study, sponsored by JCR Pharmaceuticals Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT04453085 is a Phase 1 study that has completed, run by JCR Pharmaceuticals Co.. The registered enrollment target is 14 participants.
The verdict
NCT04453085, a Phase 1 study, has completed, sponsored by JCR Pharmaceuticals Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
Phase I/II, open label, multicenter, multinational (Japan, Brazil and the US) extension study of JR-171-101 (NCT04227600) for the treatment of MPS I
Interventions
- DRUG JR-171
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-10-28 |
| Est. Completion | 2025-05-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04453085
The ClinicalTrials.gov registry entry for NCT04453085 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is JCR Pharmaceuticals Co., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JR-171 is the first listed.
NCT04453085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04453085 about?
NCT04453085 is a clinical study titled "An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)". Phase I/II, open label, multicenter, multinational (Japan, Brazil and the US) extension study of JR-171-101 (NCT04227600) for the treatment of MPS I
What is the current status of trial NCT04453085?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2021-10-28. Estimated completion is 2025-05-02.
What interventions are being tested in trial NCT04453085?
The interventions under investigation include: JR-171 (DRUG).
Who is sponsoring clinical trial NCT04453085?
This trial is sponsored by JCR Pharmaceuticals Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.